Literature DB >> 19303380

Enterovirus infections in neonates.

Marc Tebruegge1, Nigel Curtis.   

Abstract

Enteroviruses, which include echoviruses, coxsackie A and B viruses, polioviruses and the 'numbered' enteroviruses, are among the most common viruses causing disease in humans. A large proportion of enteroviral infections occur in neonates and infants. There is a wide spectrum of clinical manifestations that can be caused by enterovirus infection with varying degrees of severity. In the neonatal age group, enteroviral infections are associated with significant morbidity and mortality, particularly when infection occurs antenatally. This review provides a detailed overview of the epidemiology and clinical features of enterovirus infections in the neonatal period. In addition, laboratory features and diagnostic investigations are discussed. A review of the currently available data for prophylactic and therapeutic interventions, including antiviral therapy, is also presented.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19303380     DOI: 10.1016/j.siny.2009.02.002

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  38 in total

1.  The neonatal Fc receptor is a pan-echovirus receptor.

Authors:  Stefanie Morosky; Alexandra I Wells; Kathryn Lemon; Azia S Evans; Sandra Schamus; Christopher J Bakkenist; Carolyn B Coyne
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-11       Impact factor: 11.205

2.  Recombinant human coxsackievirus B3 from children with acute myocarditis in China.

Authors:  Zhiqiang Wu; Jiang Du; Ting Zhang; Ying Xue; Fan Yang; Qi Jin
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

3.  A new paradigm in viral resistance.

Authors:  Autumn Ruiz; Stephen J Russell
Journal:  Cell Res       Date:  2012-10-02       Impact factor: 25.617

4.  Congenital echovirus 21 infection causing fulminant hepatitis in a neonate.

Authors:  Cristina Pedrosa; Maria João Lage; Daniel Virella
Journal:  BMJ Case Rep       Date:  2013-04-09

Review 5.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

Review 6.  Early-onset neonatal sepsis.

Authors:  Kari A Simonsen; Ann L Anderson-Berry; Shirley F Delair; H Dele Davies
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

7.  Metagenomic analysis of viruses in feces from unsolved outbreaks of gastroenteritis in humans.

Authors:  Nicole E Moore; Jing Wang; Joanne Hewitt; Dawn Croucher; Deborah A Williamson; Shevaun Paine; Seiha Yen; Gail E Greening; Richard J Hall
Journal:  J Clin Microbiol       Date:  2014-10-22       Impact factor: 5.948

8.  Comparison of an in-house real-time RT-PCR assay with a commercial assay for detection of enterovirus RNA in clinical samples.

Authors:  L Selva; A Martinez-Planas; J-J García-García; R Casadevall; C Luaces; C Muñoz-Almagro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-31       Impact factor: 3.267

9.  A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis.

Authors:  Mark J Abzug; Marian G Michaels; Ellen Wald; Richard F Jacobs; José R Romero; Pablo J Sánchez; Gregory Wilson; Paul Krogstad; Gregory A Storch; Robert Lawrence; Mark Shelton; April Palmer; Joan Robinson; Penelope Dennehy; Sunil K Sood; Gretchen Cloud; Penelope Jester; Edward P Acosta; Richard Whitley; David Kimberlin
Journal:  J Pediatric Infect Dis Soc       Date:  2015-04-16       Impact factor: 3.164

10.  Type III interferons are expressed by Coxsackievirus-infected human primary hepatocytes and regulate hepatocyte permissiveness to infection.

Authors:  K Lind; E Svedin; R Utorova; V M Stone; M Flodström-Tullberg
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.